LON:BTEC Holdings Information

LON:BTEC is an equity ETF with a total of 262 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.14%, Amgen at 7.94%, Gilead Sciences at 6.99%, Regeneron Pharmaceuticals at 4.62%, and Alnylam Pharmaceuticals at 2.83%.

Total Holdings

262

Top 10 Percentage

40.90%

Asset Class

Equity

ETF Category

Health Care

Assets

721.56M

PE Ratio

23.61

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	8.14%	172,886
2	AMGN	Amgen Inc.	7.94%	229,740
3	GILD	Gilead Sciences, Inc.	6.99%	575,574
4	REGN	Regeneron Pharmaceuticals, Inc.	4.62%	76,017
5	ALNY	Alnylam Pharmaceuticals, Inc.	2.83%	98,515
6	RVMD	Revolution Medicines, Inc.	2.74%	156,869
7	BIIB	Biogen Inc.	2.16%	108,940
8	ILMN	Illumina, Inc.	1.94%	111,642
9	ARGX	argenx SE	1.77%	20,362
10	ROIV	Roivant Sciences Ltd.	1.77%	530,729
11	RPRX	Royalty Pharma plc	1.75%	327,078
12	MRNA	Moderna, Inc.	1.71%	292,780
13	UTHR	United Therapeutics Corporation	1.67%	31,321
14	INSM	Insmed Incorporated	1.64%	159,936
15	INCY	Incyte Corporation	1.55%	147,416
16	GH	Guardant Health, Inc.	1.37%	97,864
17	VTRS	Viatris Inc.	1.35%	859,308
18	NBIX	Neurocrine Biosciences, Inc.	1.19%	74,231
19	ASND	Ascendis Pharma A/S	1.17%	45,485
20	MEDP	Medpace Holdings, Inc.	1.08%	21,111
21	JAZZ	Jazz Pharmaceuticals plc	1.03%	46,354
22	BBIO	BridgeBio Pharma, Inc.	0.99%	144,742
23	EXEL	Exelixis, Inc.	0.97%	185,795
24	IONS	Ionis Pharmaceuticals, Inc.	0.94%	122,187
25	AXSM	Axsome Therapeutics, Inc.	0.88%	38,042

Showing 25 of 262 holdings

Subscribe to see the full list

Activate Now

As of Jun 25, 2026